Hypercholesterolemia  >>  Leqvio (inclisiran)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leqvio (inclisiran) / Novartis
ORION-1, NCT02597127 / 2015-003772-74: Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

Checkmark Presentation of ORION-1 data at ADA 2018
Jun 2018 - Jun 2018: Presentation of ORION-1 data at ADA 2018
Checkmark ORION-1 trial data at ADA 2018 [screenshot]
Jun 2018 - Jun 2018: ORION-1 trial data at ADA 2018 [screenshot]
Checkmark Presentation of ORION-1 data at EAS 2018
More
Completed
2
501
Canada, US, Europe
ALN-PCSSC, PCSK9 synthesis inhibitor, Inclisiran, Normal Saline
The Medicines Company
Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes
06/17
06/17

Download Options